Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Qu XW et al. Type I nitric oxide synthase (NOS) is the predominant NOS in rat small intestine. Regulation by platelet-activating factor. 1999 Biochim. Biophys. Acta pmid:10446403
Shehnaz D et al. Effect of the crude extract of Cestrum parqui on carrageenin-induced rat paw oedema and aggregation of human blood platelets. 1999 Phytother Res pmid:10441792
Dentelli P et al. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. 1999 J. Immunol. pmid:10438956
Soybir G et al. The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis. 1999 Pancreas pmid:10438161
Zeng S et al. Regulatory role of protein tyrosine phosphorylation in platelet activating factor-induced signal transduction in platelets. 1999 Zhongguo Yao Li Xue Bao pmid:10437164
Alloatti G et al. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. 1999 Cardiovasc. Res. pmid:10435033
Zouki C et al. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. 1999 Br. J. Pharmacol. pmid:10433505
Tanaka R et al. Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. 1999 Am. J. Kidney Dis. pmid:10430976
Schifitto G et al. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. 1999 Neurology pmid:10430432
Fiotti N et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 1999 Atherosclerosis pmid:10428295
Maggirwar SB et al. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. 1999 J. Neurochem. pmid:10428053
Ambrosio G and Tritto I Reperfusion injury: experimental evidence and clinical implications. 1999 Am. Heart J. pmid:10426862
Rodrigues CR et al. Proposal of a new PAF pharmacophoric map by the AM1 method. 1999 Eur J Pharm Sci pmid:10425381
Asano K et al. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. 1999 Biochem. Biophys. Res. Commun. pmid:10425216
Bocheński J et al. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats. 1999 J. Physiol. Pharmacol. pmid:10424723
Yamada M et al. Possible participation of intracellular platelet-activating factor in tumor necrosis factor-alpha production by rat peritoneal macrophages. 1999 Eur. J. Pharmacol. pmid:10422778
Shan L et al. Platelet-activating factor increases the expression of metalloproteinase-9 in human bronchial epithelial cells. 1999 Eur. J. Pharmacol. pmid:10422651
Panés J et al. Impaired mesenteric leukocyte recruitment in experimental portal hypertension in the rat. 1999 Hepatology pmid:10421653
Geijsen N et al. Regulation of p21rac activation in human neutrophils. 1999 Blood pmid:10419906
M'Rabet L et al. Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils. 1999 J. Biol. Chem. pmid:10419502
Calcerrada MC et al. Platelet-activating factor stimulation of p125(FAK) and p130(Cas) tyrosine phosphorylation in brain. 1999 Brain Res. pmid:10415383
Salas A et al. Reperfusion-induced oxidative stress in diabetes: cellular and enzymatic sources. 1999 J. Leukoc. Biol. pmid:10410990
Kudolo GB and DeFronzo RA Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. 1999 Prostaglandins Other Lipid Mediat. pmid:10410380
Li L et al. Estrogen effects on platelet-activating factor and platelet-activating factor acetylhydrolase activity in rat uterus during the late stages of pregnancy. 1999 Prostaglandins Other Lipid Mediat. pmid:10402216
Liu Q et al. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. 1999 Am Surg pmid:10399968
Shmueli O et al. Platelet-activating factor (PAF) acetylhydrolase activity, LIS1 expression, and seizures. 1999 J. Neurosci. Res. pmid:10398295
Ishii S and Shimizu T [Platelet-activating factor (PAF) receptor-related pathophysiology]. 1999 Tanpakushitsu Kakusan Koso pmid:10396985
Strukova SM et al. Modulation of mast cell activity by a peptide agonist of the thrombin receptor: role of nitric oxide. 1999 Biochemistry Mosc. pmid:10395981
Kulikov VI and Muzya GI Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets. 1999 Biochemistry Mosc. pmid:10395976
Subramanian VS et al. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. 1999 Biochim. Biophys. Acta pmid:10395969
Forte TM et al. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. 1999 J. Lipid Res. pmid:10393212
Fujii E et al. Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice. 1999 Microvasc. Res. pmid:10388605
Guilbert M et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10385597
Bandeira-Melo C et al. Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats. 1999 Br. J. Pharmacol. pmid:10385228
Deigner HP et al. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. 1999 Atherosclerosis pmid:10381281
McNeil RS et al. Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue. 1999 Cell Motil. Cytoskeleton pmid:10379835
Callea L et al. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. 1999 J. Neuroimmunol. pmid:10376955
Wang Y et al. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. 1999 May-Jun J. Soc. Gynecol. Investig. pmid:10376269
Yi FX and Guo ZG Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium. 1998 Zhongguo Yao Li Xue Bao pmid:10375790
Ji Z et al. [The role of platelet activating factor in pathogenesis of acute pancreatitis in dogs]. 1997 Zhonghua Wai Ke Za Zhi pmid:10374489
Xiao J et al. Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury. 1998 Chin. Med. J. pmid:10374355
Rosenbaum JT et al. Intravitreally injected platelet activating factor induces retinitis in experimental animals. 1999 Curr. Eye Res. pmid:10372995
Diaz E et al. Presence of platelet-activating factor in rhesus (Macaca mulatta) spermatozoa. 1999 J. Med. Primatol. pmid:10372538
Cahana A and Reiner O LIS1 and platelet-activating factor acetylhydrolase (Ib) catalytic subunits, expression in the mouse oocyte and zygote. 1999 FEBS Lett. pmid:10371146
Martínez L et al. Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. 1999 Prostaglandins Other Lipid Mediat. pmid:10367296
Steil AA et al. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. 1999 Prostaglandins Other Lipid Mediat. pmid:10367295
Goldman R et al. Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. 1999 Biochim. Biophys. Acta pmid:10366777
Crawford SE et al. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. 1999 J. Heart Lung Transplant. pmid:10363692
Del Sorbo L et al. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. 1999 Eur. J. Immunol. pmid:10359105
Weber C et al. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions. 1999 Clin. Chem. Lab. Med. pmid:10353467
Svetlov SI et al. Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. 1999 Pediatr. Nephrol. pmid:10353406
Cruzado JM et al. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. 1999 May-Jun Exp. Nephrol. pmid:10352362
Rainsford KD Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice. 1999 J. Pharm. Pharmacol. pmid:10344635
Mariano F et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. 1999 Nephrol. Dial. Transplant. pmid:10344354
Cepinskas G et al. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. 1999 J. Cell. Sci. pmid:10341212
Nasu K et al. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. 1999 Mol. Hum. Reprod. pmid:10341002
McNulty CA et al. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10340944
Yoshimura T et al. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. 1999 Maturitas pmid:10340285
Aliberti JC et al. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. 1999 Infect. Immun. pmid:10338485
Alvi SA et al. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. 1999 Mol. Hum. Reprod. pmid:10338371
Markert R and Modzelewski B [Inflammatory mediators in the acute pancreatitis]. 1999 Pol. Merkur. Lekarski pmid:10337184
Huang YH et al. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. 1999 Clin. Exp. Immunol. pmid:10337026
Latorre E et al. Platelet-activating factor modulates brain sphingomyelin metabolism. 1999 Eur. J. Biochem. pmid:10336612
Rhee CK et al. Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. 1999 Ann. Otol. Rhinol. Laryngol. pmid:10335705
Mori N et al. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. 1999 Am. J. Physiol. pmid:10330250
Flickinger BD and Olson MS Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. 1999 Am. J. Pathol. pmid:10329588
Rigat B et al. The GM2 activator protein, a novel inhibitor of platelet-activating factor. 1999 Biochem. Biophys. Res. Commun. pmid:10329374
Denizot Y et al. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? 1999 Cytokine pmid:10328869
Dong JC et al. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:10322836
Kavakli K et al. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. 1999 Thromb. Haemost. pmid:10235463
Jenks PJ et al. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects. 1999 Clin. Exp. Dermatol. pmid:10233666
Yamaguchi Y et al. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. 1999 Pancreas pmid:10231840
López-Novoa JM Potential role of platelet activating factor in acute renal failure. 1999 Kidney Int. pmid:10231429
Reinhardt JC et al. Immunofluorescent evidence of the platelet-activating factor receptor on human spermatozoa. 1999 Fertil. Steril. pmid:10231061
Hirashima Y et al. Deficient platelet-activating factor and related enzymes in hemimegalencephaly. 1999 Childs Nerv Syst pmid:10230665
Tool AT et al. Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils. 1999 Biochem. J. pmid:10229663
Han SJ et al. Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. 1999 Eur. J. Immunol. pmid:10229101
Amroyan E et al. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. 1999 Phytomedicine pmid:10228608
Bastien Y et al. Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes. 1999 J. Immunol. pmid:10228030
Harrison KA et al. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine). 1999 J Mass Spectrom pmid:10226361
Lee IS et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. 1999 Biol. Pharm. Bull. pmid:10220282
Hüseyinov A et al. Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection. 1999 Dig. Dis. Sci. pmid:10219821
Van de Weerdt ML et al. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves. 1999 Zentralbl Veterinarmed A pmid:10216447
Zardini DM and Tschirhart EJ [Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion]. 1999 Jan-Feb Therapie pmid:10216433
Nagahata Y et al. Role of platelet activating factor on severity of ischemic colitis. 1999 Dis. Colon Rectum pmid:10211499
Wang X et al. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. 1999 Int. J. Pancreatol. pmid:10211421
Klettke U et al. Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells. 1999 Mar-Apr Allergy Asthma Proc pmid:10209689
Hasselwander O et al. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. 1999 Atherosclerosis pmid:10208487
Johnson CD Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis. 1999 Dig Surg pmid:10207233
Brizzi MF et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 1999 Circ. Res. pmid:10205146
Held HD et al. Characterization of airway and vascular responses in murine lungs. 1999 Br. J. Pharmacol. pmid:10205008
Calcerrada MC et al. Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus. 1999 Biochem. Mol. Biol. Int. pmid:10204090
Wang X et al. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. 1999 Br J Surg pmid:10201790
Yamaguchi S et al. Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice. 1999 Life Sci. pmid:10201647
Park TS et al. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. 1999 J. Cereb. Blood Flow Metab. pmid:10197511
Lim H et al. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets. 1999 Biosci. Biotechnol. Biochem. pmid:10192909
Oh-hashi K et al. Dietary alpha-linolenate suppresses endotoxin-induced platelet-activating factor production in rat kidney. 1999 Lipids pmid:10188594
Uhl E et al. Influence of platelet-activating factor on cerebral microcirculation in rats: part 2. Local application. 1999 Stroke pmid:10187895
Uhl E et al. Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. 1999 Stroke pmid:10187894
Kobayashi K et al. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region. 1999 Eur. J. Neurosci. pmid:10103126